참고문헌
- Dahl, C. A., Schall, R. P., He, H. L. and Cairns, J. S. (1992) Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 148, 597-603
- Kim, S. H., Han, S. Y., Azam, T., Yoon, D. Y. and Dinarello. C. A. (2005) Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22, 131-142
- Netea, M. G., Azam, T., Ferwerda, G., Girardin, S. E., Walsh, M., Park, J. S., Abraham, E., Kim, J. M., Yoon, D. Y., Dinarello, C. A. and Kim, S. H. (2005) IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 102, 16309-16314
- Shioya, M., Nishida, A., Yagi, Y., Ogawa, A., Tsujikawa, T., Kim-Mitsuyama, S., Takayanagi, A., Shimizu, N., Fujiyama, Y. and Andoh, A. (2007) Epithelial overexpression of interleukin- 32alpha in inflammatory bowel disease. Clin. Exp. Immunol. 149, 480-486 https://doi.org/10.1111/j.1365-2249.2007.03439.x
- Novick, D., Rubinstein, M., Azam, T., Rabinkov, A., Dinarello, C. A. and Kim, S. H. (2006) Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. U.S.A. 103, 3316-3321
- Frosch, M. and Foell, D. (2004) Wegener granulomatosis in childhood and adolescence. Eur. J. Pediatr. 163, 425-434
- Lamprecht, P. and Gross, W. L. (2004) Wegener's granulomatosis. Herz 29, 47-56 https://doi.org/10.1007/s00059-004-2525-0
- Joosten, L. A., Netea, M. G., Kim, S. H., Yoon, D. Y., Oppers- Walgreen, B., Radstake, T. R., Barrera, P., van de Loo, F. A., Dinarello, C. A. and van den Berg, W. B. (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 103, 3298-3303
- Shoda, H., Fujio K., Yamaguchi Y., Okamoto A., Sawada T., Kochi, Y. and Yamamoto, K. (2006) Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res. Ther. 8, R166 https://doi.org/10.1186/ar2074
- Netea, M. G., Azam, T., Lewis, E. C., Joosten, L. A., Wang, M., Langenberg, D., Meng, X., Chan, E. D., Yoon, D. Y., Ottenhoff, T., Kim, S. H. and Dinarello, C. A. (2006) Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 3, e277 https://doi.org/10.1371/journal.pmed.0030277
- Kim, S. H., Azam, T., Yoon ,D. Y., Reznikov, L. L., Novick, D., Rubinstein, M. and Dinarello, C. A. (2001) Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein. Proc. Natl. Acad. Sci. U.S.A. 98, 3304-3309
- Kim, K. H., Shim, J. H., Seo, E. H., Cho, M. C., Kang, J. W., Kim, S. H., Yu, D. Y., Song, E. Y., Lee, H. G., Sohn, J. H., Kim, J., Dinarello, C. A. and Yoon, D. Y. (2008) Interleukin-32 monoclonal antibodies for Immunohistochemistry, Western blotting, and ELISA. J. Immunol. Methods 333, 38-50 https://doi.org/10.1016/j.jim.2007.12.017
- Goda, C., Kanaji, T., Kanaji, S., Tanaka, G., Arima, K., Ohno, S. and Izuhara, K. (2006) Involvement of IL-32 in activation-induced cell death in T cells. Int. Immunol. 18, 233-240 https://doi.org/10.1093/intimm/dxh339
- Yamamoto, Y., Kato, Z., Matsukuma, E., Li, A., Omoya, K., Hashimoto, K., Ohnishi, H. and Kondo, N. (2004) Generation of highly stable IL-18 based on a ligand-receptor complex structure. Biochem. Biophys. Res. Commun. 317, 181-186 https://doi.org/10.1016/j.bbrc.2004.03.024
- Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M. and Thomas, G. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 https://doi.org/10.1038/35079107
- Hugot, J. P., Laurent-Puig, P., Gower-Rousseau, C., Olson, J. M., Lee, J. C., Beaugerie, L., Naom, I., Dupas, J. L., Van Gossum, A., Orholm, M., Bonaiti-Pellie, C., Weissenbach, J., Mathew, C. G., Lennard-Jones, J. E., Cortot, A., Colombel, J. F. and Thomas, G. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379, 821-823 https://doi.org/10.1038/379821a0
- Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G. and Cho, J. H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 https://doi.org/10.1038/35079114
- Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G. and Flavell, R. A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 https://doi.org/10.1126/science.1104911
- Darlington, C. (2003) PEG-sTNF-RI. Amgen. Curr. Opin. Investig. Drugs 4, 583-587
- Geletka, R. C. and St. Clair, E. W. (2005) Infliximab for the treatment of early rheumatoid arthritis. Expert Opin. Biol. Ther. 5, 405-417 https://doi.org/10.1517/14712598.5.3.405
- Nahar, I. K., Shojania, K., Marra, C. A., Alamgir, A. H. and Anis, A. H. (2003) Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann. Pharmacother. 37, 1256-1265 https://doi.org/10.1345/aph.1C039
피인용 문헌
- Novel insights into the biology of interleukin-32 vol.70, pp.20, 2013, https://doi.org/10.1007/s00018-013-1301-9
- Interleukin-32 levels in gingival crevicular fluid and saliva of patients with chronic periodontitis after periodontal treatment vol.52, pp.3, 2017, https://doi.org/10.1111/jre.12404
- IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells vol.17, pp.2, 2017, https://doi.org/10.4110/in.2017.17.2.116
- Development of an interleukin (IL)-33 sandwich ELISA kit specific for mature IL-33 vol.37, pp.6, 2016, https://doi.org/10.1080/15321819.2016.1179645
- Interleukin 32 (IL-32) Contains a Typical α-Helix Bundle Structure That Resembles Focal Adhesion Targeting Region of Focal Adhesion Kinase-1 vol.287, pp.8, 2012, https://doi.org/10.1074/jbc.M111.288290
- Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression vol.65, pp.1, 2014, https://doi.org/10.1016/j.cyto.2013.09.017
- Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha vol.14, pp.3, 2012, https://doi.org/10.1186/ar3850
- Paradoxical effects of constitutive human IL-32 in transgenic mice during experimental colitis vol.107, pp.49, 2010, https://doi.org/10.1073/pnas.1015418107
- Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation vol.40, pp.11, 2015, https://doi.org/10.1007/s11064-015-1714-y
- Elevated interleukin-32 expression in granulomatosis with polyangiitis vol.51, pp.11, 2012, https://doi.org/10.1093/rheumatology/kes163
- Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients 2014, https://doi.org/10.1007/s00430-014-0329-2
- Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection vol.58, pp.1, 2012, https://doi.org/10.1016/j.cyto.2011.12.024
- Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response vol.89, pp.1, 2011, https://doi.org/10.1007/s00109-010-0677-3